McKesson Corporation (0JZU.L)
USD 693.0
(0.42%)
USD 693.0
(0.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 12.58 Billion USD | 6.02% |
| 2022 | 11.86 Billion USD | -6.17% |
| 2021 | 12.64 Billion USD | 9.21% |
| 2020 | 11.58 Billion USD | 1.6% |
| 2019 | 11.4 Billion USD | 5.93% |
| 2018 | 10.76 Billion USD | 3.56% |
| 2017 | 10.39 Billion USD | -2.77% |
| 2016 | 10.68 Billion USD | -2.33% |
| 2015 | 10.94 Billion USD | -4.11% |
| 2014 | 11.41 Billion USD | 35.23% |
| 2013 | 8.43 Billion USD | 22.46% |
| 2012 | 6.89 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.15 Billion USD | -8.98% |
| 2023 Q1 | 2.8 Billion USD | -5.36% |
| 2023 Q2 | 2.89 Billion USD | 3.17% |
| 2023 FY | 12.2 Billion USD | 2.81% |
| 2023 Q3 | 3.03 Billion USD | 4.62% |
| 2023 Q4 | 3.46 Billion USD | 14.22% |
| 2022 Q2 | 3 Billion USD | 2.42% |
| 2022 Q1 | 2.93 Billion USD | -8.82% |
| 2022 Q4 | 2.96 Billion USD | 0.34% |
| 2022 FY | 11.86 Billion USD | -6.17% |
| 2022 Q3 | 2.95 Billion USD | -1.63% |
| 2021 FY | 12.64 Billion USD | 9.21% |
| 2021 Q1 | 2.89 Billion USD | -8.42% |
| 2021 Q2 | 3.22 Billion USD | 11.44% |
| 2021 Q4 | 3.22 Billion USD | -2.72% |
| 2021 Q3 | 3.31 Billion USD | 2.64% |
| 2020 Q4 | 3.16 Billion USD | 0.29% |
| 2020 FY | 11.58 Billion USD | 1.6% |
| 2020 Q1 | 2.7 Billion USD | -18.53% |
| 2020 Q2 | 3 Billion USD | 11.11% |
| 2020 Q3 | 3.15 Billion USD | 5.03% |
| 2019 Q3 | 3.03 Billion USD | 5.79% |
| 2019 Q4 | 3.31 Billion USD | 9.26% |
| 2019 Q1 | 2.78 Billion USD | -12.93% |
| 2019 Q2 | 2.86 Billion USD | 2.87% |
| 2019 FY | 11.4 Billion USD | 5.93% |
| 2018 FY | 10.76 Billion USD | 3.56% |
| 2018 Q4 | 3.2 Billion USD | 7.78% |
| 2018 Q3 | 2.97 Billion USD | 5.92% |
| 2018 Q2 | 2.8 Billion USD | 0.9% |
| 2018 Q1 | 2.77 Billion USD | -9.63% |
| 2017 Q1 | 2.56 Billion USD | -8.44% |
| 2017 Q2 | 2.83 Billion USD | 10.7% |
| 2017 Q3 | 2.71 Billion USD | -4.2% |
| 2017 Q4 | 3.07 Billion USD | 13.26% |
| 2017 FY | 10.39 Billion USD | -2.77% |
| 2016 FY | 10.68 Billion USD | -2.33% |
| 2016 Q4 | 2.79 Billion USD | -0.57% |
| 2016 Q3 | 2.81 Billion USD | 2.03% |
| 2016 Q2 | 2.75 Billion USD | -5.19% |
| 2016 Q1 | 2.9 Billion USD | 1.75% |
| 2015 FY | 10.94 Billion USD | -4.11% |
| 2015 Q4 | 2.85 Billion USD | -0.73% |
| 2015 Q3 | 2.87 Billion USD | 1.2% |
| 2015 Q1 | 2.8 Billion USD | -3.87% |
| 2015 Q2 | 2.84 Billion USD | 1.43% |
| 2014 Q4 | 2.91 Billion USD | 0.62% |
| 2014 FY | 11.41 Billion USD | 35.23% |
| 2014 Q1 | 2.73 Billion USD | 3.68% |
| 2014 Q2 | 2.86 Billion USD | 4.83% |
| 2014 Q3 | 2.89 Billion USD | 1.22% |
| 2013 FY | 8.43 Billion USD | 22.46% |
| 2013 Q1 | 1.93 Billion USD | -3.31% |
| 2013 Q3 | 1.85 Billion USD | -8.31% |
| 2013 Q4 | 2.63 Billion USD | 42.2% |
| 2013 Q2 | 2.02 Billion USD | 4.72% |
| 2012 Q3 | 1.63 Billion USD | 0.0% |
| 2012 Q4 | 1.99 Billion USD | 21.93% |
| 2012 FY | 6.89 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -6137.577% |
| Accuray Incorporated | 143.12 Million USD | -8692.56% |
| Align Technology, Inc. | 2.72 Billion USD | -362.619% |
| Elevance Health Inc. | 47.01 Billion USD | 73.231% |
| AxoGen, Inc. | 127.87 Million USD | -9740.937% |
| Boston Scientific Corporation | 9.84 Billion USD | -27.769% |
| CVS Health Corporation | 54.43 Billion USD | 76.881% |
| Cardinal Health, Inc. | 7.41 Billion USD | -69.733% |
| Centene Corporation | 153.99 Billion USD | 91.829% |
| DaVita Inc. | 3.82 Billion USD | -229.387% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 77.147% |
| Hologic, Inc. | 2.23 Billion USD | -462.338% |
| Humana Inc. | 106.44 Billion USD | 88.177% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -474.62% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -273.978% |
| Masimo Corporation | 1 Billion USD | -1154.011% |
| Patterson Companies, Inc. | 1.38 Billion USD | -811.724% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -324.992% |
| ResMed Inc. | 2.6 Billion USD | -382.371% |
| Henry Schein, Inc. | 3.65 Billion USD | -244.673% |
| Teladoc Health, Inc. | 1.84 Billion USD | -583.028% |
| Universal Health Services, Inc. | 1.17 Billion USD | -970.632% |
| Veeva Systems Inc. | 1.68 Billion USD | -646.213% |
| Baxter International Inc. | 4.97 Billion USD | -152.945% |
| Becton, Dickinson and Company | 8.82 Billion USD | -42.627% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -166.075% |
| Danaher Corporation | 14.12 Billion USD | 10.935% |
| Stryker Corporation | 13.05 Billion USD | 3.63% |
| Medtronic plc | 21.27 Billion USD | 40.845% |